J Rheumatol. 2008 Jan;35(1):172-4.

Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica.

Source

Department of Medicine and Radiology, Tuen Mun Hospital, Hong Kong SAR. ccmok2005@yahoo.com

Abstract

Neuromyelitis optica (NMO), or Devic's disease, is an aggressive inflammatory disease of the central nervous system that predominantly affects the optic nerves and the spinal cord. The association with other systemic autoimmune diseases and the discovery of the specific biomarker, NMO-immunoglobulin G (IgG), suggests that NMO is autoimmune in origin. The prognosis of NMO is grave, especially in those patients with early and recurrent relapses. We describe successful use of immunoablative cyclophosphamide in halting relapses in a patient with systemic lupus erythematosus-associated NMO who was unresponsive to high-dose oral and intravenous corticosteroids, intravenous immunoglobulin, mycophenolate mofetil, tacrolimus, low-dose daily oral cyclophosphamide and rituximab.

PMID:: 18176991; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Case Reports

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. [Lupus. 1999]
Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus.
Bonnet F, Mercié P, Morlat P, Hocke C, Vergnes C, Ellie E, Viallard JF, Faure I, Pellegrin JL, Beylot J, et al. Lupus. 1999; 8(3):244-7.
Devic's syndrome as initial presentation of systemic lupus erythematosus. [Am J Med Sci. 2009]
Devic's syndrome as initial presentation of systemic lupus erythematosus.
Karim S, Majithia V. Am J Med Sci. 2009 Sep; 338(3):245-7.
Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus. [Arch Neurol. 2009]
Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus.
Nasir S, Kerr DA, Birnbaum J. Arch Neurol. 2009 Sep; 66(9):1160-3.
Review Neuromyelitis optica. [Int MS J. 2006]
Review Neuromyelitis optica.
Wingerchuk DM. Int MS J. 2006 May; 13(2):42-50.
Review Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker. [Curr Top Microbiol Immunol. 2008]
Review Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.
Weinshenker BG, Wingerchuk DM. Curr Top Microbiol Immunol. 2008; 318:343-56.

See reviews... See all...

Cited by 4 PubMed Central articles

Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices. [Curr Neuropharmacol. 2011]
Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices.
Awad A, Stüve O. Curr Neuropharmacol. 2011 Sep; 9(3):417-28.
Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. [Neurol Res Int. 2012]
Neuromyelitis optica: an antibody-mediated disorder of the central nervous system.
Oh J, Levy M. Neurol Res Int. 2012; 2012:460825. Epub 2012 Jan 29.
Current and future treatment approaches for neuromyelitis optica. [Ther Adv Neurol Disord. 2011]
Current and future treatment approaches for neuromyelitis optica.
Collongues N, de Seze J. Ther Adv Neurol Disord. 2011 Mar; 4(2):111-21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optic...
Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica.
J Rheumatol. 2008 Jan ;35(1):172-4.

PubMed
Midkine secretion protects Hep3B cells from cadmium induced cellular damage.
Midkine secretion protects Hep3B cells from cadmium induced cellular damage.
World J Gastroenterol. 2008 Jan 7 ;14(1):76-80.

PubMed
Feasibility and acceptability of DVD and telephone coaching-based skills trainin...
Feasibility and acceptability of DVD and telephone coaching-based skills training for carers of people with an eating disorder.
Int J Eat Disord. 2008 May ;41(4):318-25.

PubMed
Gender-dependent differences in serum profiles of insulin and leptin in caloric ...
Gender-dependent differences in serum profiles of insulin and leptin in caloric restricted rats.
Horm Metab Res. 2008 Jan ;40(1):38-43. Epub 2008 Jan 7 .

PubMed
Interaction of conspecific cues in Balanus amphitrite Darwin (Cirripedia) settle...
Interaction of conspecific cues in Balanus amphitrite Darwin (Cirripedia) settlement assays: continued argument for the single-larva assay.
Biofouling. 2008 ;24(2):87-96.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information